“…Over the last decade, scientific research related to these events has been performed to investigate biological, diagnostic, and prognostic parameters. [3][4][5][6][7][8] These include growth factors and their receptors, signal transducers, transcription factors, cell cycle regulators, p53, proliferative and apoptotic proteins, cyclooxygenase 2, nuclear factor kappa B, hypoxia-related proteins, and angiogenesis. [3][4][5][6][7][8] In head and neck cancer, except for epidermal growth factor receptor (EGFR), there are few studies that have correlated the protein expression of signal transducer and activator of transcription 3 (Stat3), c-myc, and H-ras with clinicopathologic parameters.…”